Navigation Links
Anadys Pharmaceuticals Reports Second Quarter 2009 Financial Results and Program Highlights
Date:7/30/2009

accordance with SFAS No. 123(R) or approximately $0.06 and $0.05 effect on basic and diluted net loss per common share for the six months ended June 30, 2009 and 2008, respectively. Research and development expense and general and administrative expense includes $944 and $802, respectively, of non-cash operating expenses determined in accordance with SFAS No. 123(R) for the six months ended June 30, 2009.

                         Anadys Pharmaceuticals, Inc.
                    Condensed Consolidated Balance Sheets
                                (In thousands)

                                                      June 30,    December 31,
                                                        2009          2008
                                                     (Unaudited)    (Audited)
    Assets

    Cash, cash equivalents and securities
     available-for-sale                                $30,620      $27,936
    Other current assets                                 2,576        2,202
    Noncurrent assets                                      956        1,536
                                                       -------      -------
        Total assets                                   $34,152      $31,674
                                                       =======      =======

    Liabilities and Stockholders' Equity

    Current liabilities                                 $8,733       $5,813
    Other long-term liabilities                             32           36
    Stockholders' equity                                25,387       25,825
                                                       -------      -------
        Total liabilities and stockholders' equity     $34,152      $31,674
                                                       =======      =======

Pegasys(R) and Copegus(R) are registe
'/>"/>

SOURCE Anadys Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. Anadys Pharmaceuticals to Report Second Quarter 2009 Financial Results
2. Anadys Pharmaceuticals, Inc. Announces Strategic Restructuring to Focus Operations on Continuing the Advancement of ANA598
3. Anadys Pharmaceuticals Reports First Quarter 2009 Financial Results and Highlights
4. Anadys Pharmaceuticals to Report First Quarter 2009 Financial Results
5. Anadys Pharmaceuticals to Present at Future Leaders in the Biotech Industry
6. Anadys Pharmaceuticals to Present at the Piper Jaffray Health Care Conference
7. Anadys Pharmaceuticals to Present at the Needham Focus on Infectious Disease Conference
8. Anadys Pharmaceuticals to Present at Rodman & Renshaw Annual Global Investment Conference
9. Anadys Pharmaceuticals Commences Dosing ANA773 in Hepatitis C Patients
10. Anadys Pharmaceuticals Reports Third Quarter 2008 Financial Results and Highlights
11. Anadys Pharmaceuticals to Present at BIOCOM Investor Conference 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/30/2015)... , April 30, 2015  Asterias Biotherapeutics, Inc. (NYSE ... field of regenerative medicine, today announced that it will ... May 7, 2015 after the close of the U.S. ... and webcast on Thursday, May 7, 2015 at 4:30 ... results and recent corporate developments. For both ...
(Date:4/30/2015)... 30, 2015 Available in select ... http://www.lespausa.com , Phytomer’s DOUCEUR INTEMPORELLE Restorative Shield ... skin while battling the weakening threat of inflammaging, ... is formulated with star ingredient GLYCOSEA, a complex ... a complex of soothing minerals and trace elements. ...
(Date:4/29/2015)... April 30, 2015 According to ... Market by Product (Portable & Non-Portable), Component (Accelerometer, ... Automotive, Chemical, Metal & Mining, & Others), & ... market is expected to reach $1,453.76 Million by ... 71 market data tables and 92 figures spread ...
(Date:4/29/2015)... , April 29, 2015 Cambrex Corporation (NYSE: ... will be released on Friday, May 1, 2015 before the ... The Company will host a conference call to discuss ... When: , Friday, May 1, 2015 ... , 1-888-468-2440 for U.S.1-719-325-2454 for International  Passcode:  7993632 ...
Breaking Biology Technology:Asterias Biotherapeutics to Report First Quarter Results on May 7, 2015 2Asterias Biotherapeutics to Report First Quarter Results on May 7, 2015 3Phytomer introduces DOUCEUR INTEMPORELLE Restorative Shield Cream 2Phytomer introduces DOUCEUR INTEMPORELLE Restorative Shield Cream 3Vibration Monitoring Equipment (Portable & Non-Portable) Market worth $1,453.76 Million by 2020 - New Report by MarketsandMarkets 2Vibration Monitoring Equipment (Portable & Non-Portable) Market worth $1,453.76 Million by 2020 - New Report by MarketsandMarkets 3Vibration Monitoring Equipment (Portable & Non-Portable) Market worth $1,453.76 Million by 2020 - New Report by MarketsandMarkets 4
... integrating patient medical information securely and seamlessly across multiple ... the Midwest. , ,A recent partnership between Symphony ... CareEvolution seeks to implement a novel clinical information-sharing ... so-called "federated" model utilizes a peer-to-peer record locator service ...
... A Wisconsin-based portal to educational information about books ... from the Association of Educational Publishers . ... supplemental educational resources for nearly three decades, honored ... category titled "Portal for Young Adults and Children." ...
... generation ago, then-Gov. Lee Dreyfus made a few waves ... should become "the blue-eyed Arabs of the Upper Midwest" ... , ,Like many of his ideas, often delivered ... about them, this Dreyfus proposal simultaneously stirred the imagination ...
Cached Biology Technology:Symphony Corp. and CareEvolution to partner 2Fresh water could be a deep economic wellspring for Wisconsin 2Fresh water could be a deep economic wellspring for Wisconsin 3
(Date:3/24/2015)... March 24, 2015   NexID Biometrics LLC, ... security-authentication needs, today announced the beginning of shipments of ... The company, based in Potsdam, ... three-day Connect:ID Expo, which began here today at the ... version 2.0 of its SDK boosts the accuracy rate ...
(Date:3/23/2015)... 2015 SoundView Technology Group issues a new research ... ) Wocket smart wallet. SoundView was one of the selected user ... with the Wocket in multiple scenarios and outlets. ... other retailers, making both debit and credit card payments.  ... "If the company meets their plans in 2015, it would ...
(Date:3/23/2015)... -- In the 2014 fiscal year, irs.gov recorded over $100 ... accounts for a fraction of the estimated losses for ... $11 billion globally. The polygraph has traditionally been used ... Investor Mark Saint Juste along with former ... partnered to administer the test in a new way: ...
Breaking Biology News(10 mins):NexID Begins Shipments Of Version 2.0 Fake-Finger-Detection Solution 2Technology Research Note Update from SoundView; Real-World Usage and Feedback of Wocket Smart Wallet at CVS, Whole Foods and other Retailers 2Technology Research Note Update from SoundView; Real-World Usage and Feedback of Wocket Smart Wallet at CVS, Whole Foods and other Retailers 3Technology Research Note Update from SoundView; Real-World Usage and Feedback of Wocket Smart Wallet at CVS, Whole Foods and other Retailers 4Polygraph Test Now Used to Protect Investors From Fraud 2Polygraph Test Now Used to Protect Investors From Fraud 3
... Richer, speaking at his 4th annual Nutrition & The Eye ... the University of Missouri in St. Louis, says molecular medicine ... when all other therapies have been exhausted. "These nutritional ... in cardiology , cancer research and some human studies", Dr ...
... 14, 2011 Novocure today announced that the ... NovoTTF-100A System (NovoTTF) for the treatment of adult ... tumor recurrence after receiving chemotherapy. The portable, ... patients maintain their normal daily activities. The NovoTTF ...
... A team led by researchers at the National Institutes of ... the melanoma genome, the DNA code of the deadliest form ... using whole-exome sequencing, an approach that decodes the 1-2 percent ... in the April 15, 2011, early online issue of ...
Cached Biology News:Low-cost molecular medicine should be included in modern eye physicians' tool kit 2FDA approves the NovoTTF-100A system for the treatment of patients with recurrent glioblastoma multiforme (GBM) brain tumors 2NIH researchers complete whole-exome sequencing of skin cancer 2NIH researchers complete whole-exome sequencing of skin cancer 3NIH researchers complete whole-exome sequencing of skin cancer 4NIH researchers complete whole-exome sequencing of skin cancer 5
TP-1 (NDOG1)...
Ras-related C3 botulinum toxin substrate 1...
Mouse monoclonal [6G11] to Cytohesin 1 + 2 ( Abpromise for all tested applications)....
... Express Cloning Checker Kits provide two ... after transformation without time-consuming plasmid preparation. By ... I, all you need to do is ... bacteria directly from the transformation plates into ...
Biology Products: